Clinical Trial Update: A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating STEMVAC in combination with chemotherapy for PD-L1 negative metastatic triple-negative breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• STEMVAC

Snippet

Sponsor: University of Washington | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma | Phase 2 | Status: RECRUITING